Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A2UV
|
||||
Former ID |
DCL001030
|
||||
Drug Name |
Ustekinumab
|
||||
Synonyms |
Stelara (TN)
|
||||
Drug Type |
Antibody
|
||||
Company |
Centocor Ortho Biotech
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H18Cl3N5O2
|
||||
PubChem Compound ID | |||||
SuperDrug ATC ID |
L04AC05
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-23 ligand | Target Info | [530677], [536371], [537117] | ||
Interleukin-12 | Target Info | [530677], [536371], [537117] | |||
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Toll-like receptor signaling pathway | |||||
RIG-I-like receptor signaling pathway | |||||
Jak-STAT signaling pathway | |||||
Type I diabetes mellitus | |||||
Pertussis | |||||
Legionellosis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
African trypanosomiasis | |||||
Malaria | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Measles | |||||
Influenza A | |||||
Herpes simplex infection | |||||
Inflammatory bowel disease (IBD) | |||||
Allograft rejectionhsa04060:Cytokine-cytokine receptor interaction | |||||
Allograft rejection | |||||
Pathway Interaction Database | IL27-mediated signaling events | ||||
IL12-mediated signaling events | |||||
References | |||||
Ref 530677 | Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. | ||||
Ref 541942 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6885). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.